masoprocol has been researched along with Leukemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassett, D; Beaudry, C; Bogenberger, JM; Carpten, J; Frazer, N; Garcia, R; Hagelstrom, RT; Kim, S; Lekakis, L; McDonagh, KT; Mohrland, S; Schroeder, K; Shanmugam, V; Shea, TC; Tibes, R; Von Hoff, D | 1 |
| Apraiz, A; Asumendi, A; Boyano, MD; Hannun, YA; Idkowiak-Baldys, J; Nieto-Rementería, N | 1 |
| Andreeff, M; Carter, BZ; Chen, W; Heller, J; Mak, DH; Schober, WD | 1 |
| Ayyub Khan, M; Hoffbrand, AV; Tateson, JE; Wickremasinghe, RG | 1 |
| Brass, LF; Woolkalis, MJ | 1 |
| Cullen, MK; Kobb, SM; Miller, AM; Weiner, RS | 1 |
1 trial(s) available for masoprocol and Leukemia
| Article | Year |
|---|---|
Phase I study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemias.
Topics: Adult; Aged; Antineoplastic Agents; CDC2 Protein Kinase; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Leukemia; Liver Function Tests; Male; Masoprocol; Maximum Tolerated Dose; Middle Aged; Polyethylene Glycols; Remission Induction | 2015 |
5 other study(ies) available for masoprocol and Leukemia
| Article | Year |
|---|---|
Dihydroceramide accumulation and reactive oxygen species are distinct and nonessential events in 4-HPR-mediated leukemia cell death.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Ascorbic Acid; Cell Line, Tumor; Cell Survival; Ceramides; Fenretinide; Flavanones; Humans; Leukemia; Lipid Peroxidation; Lipoxygenase Inhibitors; Masoprocol; Mitochondria; Oxidative Stress; Oxidoreductases; Reactive Oxygen Species; Sphingolipids; Vitamin E | 2012 |
Tetra-O-methyl nordihydroguaiaretic acid inhibits growth and induces death of leukemia cells independent of Cdc2 and survivin.
Topics: Antioxidants; Apoptosis; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Inhibitor of Apoptosis Proteins; Jurkat Cells; Leukemia; Masoprocol; Microtubule-Associated Proteins; Mitochondria; Neoplasm Proteins; Survivin; U937 Cells | 2007 |
Evidence that endogenous generation of leukotrienes does not regulate proliferation of malignant hemopoietic cell lines.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Benzeneacetamides; Blast Crisis; Burkitt Lymphoma; Cell Division; Epoprostenol; Hematopoietic System; Humans; Hydroxamic Acids; Indoles; Leukemia; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Masoprocol; Tumor Cells, Cultured | 1993 |
Dual regulation of cyclic AMP formation by thrombin in HEL cells, a leukaemic cell line with megakaryocytic properties.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Adenylate Cyclase Toxin; Calcium; Cell Line; Cell Membrane; Colforsin; Cyclic AMP; Cytosol; Epinephrine; Epoprostenol; Humans; Inositol Phosphates; Kinetics; Leukemia; Masoprocol; Megakaryocytes; Pertussis Toxin; Thrombin; Trypsin; Virulence Factors, Bordetella | 1992 |
Effects of lipoxygenase and glutathione pathway inhibitors on leukemic cell line growth.
Topics: Buthionine Sulfoximine; Caffeic Acids; Dose-Response Relationship, Drug; Glutathione; Hematopoietic Stem Cells; Humans; Leukemia; Leukotrienes; Lipoxygenase; Lipoxygenase Inhibitors; Masoprocol; Methionine Sulfoximine; Tumor Cells, Cultured | 1989 |